Metadata
- Name
- Ascorbic Acid Treatment in CMT1A Trial (AATIC)
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT00271635
- Description
- Charcot-Marie-Tooth type IA (CMT1A) is the most prevalent hereditary peripheral neuropathy.
Demyelination of peripheral nerves is the hallmark of CMT1A. Ascorbic acid has been shown to
have a favorable influence on myelination in in vitro studies and in a mouse model for CMT1A.
We will study the efficacy and safety of ascorbic acid treatment in young patients with
CMT1A. - Data or Study Types
- clinical trial
- Keywords
- Hereditary Motor and Sensory Neuropathies, Ascorbic Acid, Charcot-Marie-Tooth Disease, Vitamin C
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2006
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT00271635
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT00271635